-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.0051.19% Upside
Corvus Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Corvus Pharmaceuticals, Inc.?
Corvus Pharmaceuticals, Inc. has been rated by research analysts at Oppenheimer in the past 90 days.